Skip to main content
Premium Trial:

Request an Annual Quote

Orchid Receives Another DNA Genotyping Patent

Premium

P

RINCETON, NJ--Orchid Biocomputer said that it has received a key genotyping technology patent that adds to the company’s SNP patent portfolio and supports its primer extension genotyping technology. "Orchid is making primer extension genotyping technology widely available in the form of its own products and services as well as by entering into collaborations with other leading companies that rely on genotyping technologies to conduct their research and develop products," said Michael Boyce-Jacino, Orchid’s vice-president of genomics R&D. The company expects the new patent to improve the development process of pharmaceutical products in multiple markets.

Filed under

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.